A Phase 3 Study Evaluating The Efficacy And Safety Of Benralizumab In Patients With Hypereosinophilic Syndrome
- Resource Type
- Source
- Journal of Allergy and Clinical Immunology. 151:AB111
- Subject
Immunology Immunology and Allergy - Language
- ISSN
- 0091-6749